Akcea Therapeutics, Inc. (AKCA) PT Lowered to $44 at Wells Fargo
Tweet Send to a Friend
Wells Fargo analyst Jim Birchenough lowered the price target on Akcea Therapeutics, Inc. (NASDAQ: AKCA) to $44.00 (from $46.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
